Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. - Wikidata - wikimedia - TriplyDB

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

http://www.wikidata.org/entity/Q34038244

about

Properties, production, and applications of camelid single-domain antibody fragments The staphylococcal enterotoxin (SE) family: SEB and siblings Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs Antibody to ricin a chain hinders intracellular routing of toxin and protects cells even after toxin has been internalized Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin A Single-Domain Llama Antibody Potently Inhibits the Enzymatic Activity of Botulinum Neurotoxin by Binding to the Non-Catalytic α-Exosite Binding Region Enhancing the Protective Immune Response against Botulism Yeast mating for combinatorial Fab library generation and surface display Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity Monoclonal antibody therapies against anthrax Antibodies for biodefense Characterization of botulinum neurotoxin type A neutralizing monoclonal antibodies and influence of their half-lives on therapeutic activity Production and characterisation of a neutralising chimeric antibody against botulinum neurotoxin A Engineered single-domain antibodies with high protease resistance and thermal stability Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A Enhanced neutralization potency of botulinum neurotoxin antibodies using a red blood cell-targeting fusion protein Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor.Multi-wavelength Spatial LED illumination based detector for in vitro detection of Botulinum Neurotoxin A Activity.Botulinum toxin type B micromechanosensor.Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies.Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin Characterization of a novel high-affinity monoclonal immunoglobulin G antibody against the ricin B subunit.Synthesis, characterization and development of a high-throughput methodology for the discovery of botulinum neurotoxin a inhibitors.Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.Synthetic antibodies as therapeutics.Neutralization of botulinum neurotoxin by a human monoclonal antibody specific for the catalytic light chain.Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.Identification of recombinant antibodies against multiple distinct toll-like receptors by homolog mining a single immune scFv phage library Mouse in vivo neutralization of Escherichia coli Shiga toxin 2 with monoclonal antibodies Back to the future: recombinant polyclonal antibody therapeutics.Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigen Neutralizing antibodies of botulinum neurotoxin serotype A screened from a fully synthetic human antibody phage display library.Lab-on-a-chip for botulinum neurotoxin a (BoNT-A) activity analysis.Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents.Affinity maturation of human botulinum neurotoxin antibodies by light chain shuffling via yeast mating.Characterisation of a panel of anti-tetanus toxin single-chain Fvs reveals cooperative binding Progress towards recombinant anti-infective antibodies.Efficient serum clearance of botulinum neurotoxin achieved using a pool of small antitoxin binding agents.Identification of internalizing human single-chain antibodies targeting brain tumor sphere cells.

P2860

Q24676749-C5C2B1E3-7F96-48A2-97FC-0B3EE658C814 Q26830220-07743002-AC6B-4CC9-A979-3FC515F4A521 Q26863621-2C046B9C-E382-4397-B1AB-D3FB8605FCB5 Q27322604-733388F7-0439-4E24-A90F-0DFBCEAD0AE6 Q27643327-4601388B-469C-4060-84ED-D990D980F9EB Q27659624-E64871B7-9FEA-4855-AF07-35A40B5EA494 Q27678122-C5D42BCA-CFED-424C-944B-67CE934C48DF Q28257249-1B2C8CBC-66E8-4013-BC17-67633B15A053 Q28302768-3EA5F0F5-D987-4D94-A772-5551D8C85A7B Q28383065-32035BA5-4345-4321-A6A0-9FC527ACF57D Q28393072-79BD6A96-BA0C-4819-BEFE-CF7711BF8BD0 Q28394941-3D1E9AD5-41C1-444E-B0AE-F3EB2743BA19 Q28475305-CE3C8825-56D2-4E68-A8F2-8F325C088E58 Q28475753-471FDB8C-E91A-4E6E-8235-4595FA344A56 Q28478199-55F26B40-F967-457D-990B-7B50672AC99C Q28581589-CA2EEB72-686C-4A77-85B8-229B0929B800 Q28742292-05D4CAC2-4327-4622-A7E6-EF0BF49A4E04 Q30408386-84E35049-A555-4AFB-9531-AFA2A1AD9696 Q30494601-886C0A4A-5637-4FB7-BD57-A04167B994E4 Q30501213-60DDA896-707F-4974-84DD-8A5202494A1E Q30862040-61DB6AF4-7B31-47BD-BD68-03210131D551 Q31042202-6931A544-CBE8-4B4A-B435-1D3FBE571CCA Q33244199-A9173B22-5FA9-44F2-B9C9-F8100D89245C Q33249268-E58DE3C3-706D-4CE8-95A3-AEBF33FFD99C Q33261279-06B4B811-A73C-458C-8141-84EA30A6C705 Q33265617-54866470-D052-483F-A26A-77F5288BAA25 Q33361666-D52C12A6-60F8-4959-AB35-EBB90745B484 Q33363266-DA75A697-F80A-46B0-8BD2-6675AC74FB4B Q33385401-F851C0F0-C6B8-43C6-B6C0-F5FAA738F499 Q33411089-0EBF4946-4D60-421C-B4EE-82D033F0FA33 Q33412776-3FE3EB7F-CF3F-47C4-B8FE-49CE2B72D2E4 Q33496407-E8F3CF8D-9D7C-445A-A56E-F35FCE1F0A45 Q33499630-5AB40EEB-0D58-41E3-A06D-45D6693765EA Q33513499-5BEBCE5A-0672-4594-89C9-B82433448A47 Q33526251-D22C6D9D-743C-440C-A0EB-E4ECE8463B6D Q33531378-0EF21EA0-907C-487C-B8C1-B6CABA5C33F7 Q33562483-7647A01E-F724-4DB0-9FC1-EFE4D1D54A41 Q33568256-CC5B120E-07A5-471E-A162-5F5D63D04C58 Q33613925-99CB92C5-8716-4ECA-BB98-4C5EBF63473D Q33620053-572C6841-FABE-4CAB-889E-98878FC6FE03

P2860

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

http://www.wikidata.org/entity/Q34038244

description

2002 nî lūn-bûn

@nan

2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

@ast

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

@en

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

@nl

type

label

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

@ast

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

@en

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

@nl

prefLabel

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

@ast

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

@en

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

@nl

P1433

Q34038244-E1873279-43F7-4E64-8A96-5044314DA844

P1476

Q34038244-83832630-A26F-4CEA-8225-33BD74A79268

P2093

Q34038244-011A79E8-DADF-4079-A523-83A6D10C6356

Q34038244-5FC12D8B-FB4F-461F-AAC0-06DC2CAB788F

Q34038244-6E81D935-01B6-419D-9DA7-286FA307854C

Q34038244-8B75036D-51D6-476D-BCFD-7404DD84770A

Q34038244-AE90AF28-73CE-4843-AB5B-10EE78CDEEB9

Q34038244-AFFA6D79-EA8E-4062-B091-24B72905A3E0

Q34038244-B50C5B2E-B280-4854-B6E4-4C3DCE191C37

Q34038244-DBC000E7-62C9-4E7A-BB3B-4BC9F708E090

Q34038244-DC89E5B5-C734-4410-B876-704B12D8E4C3

Q34038244-FA3E3C7F-7B40-410E-B91C-E2CE1D561B0B

P2860

Q34038244-053DB78C-0E02-4EED-8004-D575C40A501B

Q34038244-0A5D6C7F-4C64-4CDF-9EE6-6662C7D89797

Q34038244-12602F32-A1D1-4F2A-AFA6-D3CF422F761E

Q34038244-140CD76A-1A58-466B-8C31-F88E57BAC2A0

Q34038244-226B90E1-18D9-4439-9D2E-862D37684478

Q34038244-27480D17-DA95-44B6-AFD2-A28F5AB2B8F5

Q34038244-367CB12D-D3A6-47C5-AB3B-236BBBD57FBE

Q34038244-565F9C62-5560-4801-8A81-37975A1491D7

Q34038244-5996A81E-A19D-47D7-8EFB-A0001EE66C3B

Q34038244-6ADCF451-63ED-4323-BE2C-103D1D338217

P304

Q34038244-7A9C32D7-E0C9-46DB-9DE0-D8A2AD7EE506

P31

Q34038244-17556C43-4CE8-426E-BFFA-9C36DD2E5AB7

P356

Q34038244-48D24AA6-08BC-49DA-9329-DAF39A3DCAA1

P407

Q34038244-81274276-E3FE-4C9C-ABA4-A8081BDC0C52

P433

Q34038244-E0ECB4D1-BC22-4379-B352-43ADF8A7A5EF

P478

Q34038244-DF11C62D-4076-45A8-B8AB-B66E550C11F4

P577

Q34038244-777F8E07-25E1-4161-A8C6-029B40BAABB6

P5875

Q34038244-4BA579FF-32D8-4222-B5EF-189861235F0D

P698

Q34038244-3330665A-B208-49D1-8985-722184192342

P921

Q34038244-ED89E2C9-DD37-48B2-8B85-C3D79952F907

P932

Q34038244-64C175A5-CFF6-4A66-B340-7AB4FEDB9BE6

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

@en

P2093

A Nowakowski

http://www.w3.org/2001/XMLSchema#string

C Wang

http://www.w3.org/2001/XMLSchema#string

D B Powers

http://www.w3.org/2001/XMLSchema#string

J D Marks

http://www.w3.org/2001/XMLSchema#string

L A Smith

http://www.w3.org/2001/XMLSchema#string

P Amersdorfer

http://www.w3.org/2001/XMLSchema#string

R Blake

http://www.w3.org/2001/XMLSchema#string

R Sheridan

http://www.w3.org/2001/XMLSchema#string

T J Smith

http://www.w3.org/2001/XMLSchema#string

V A Montgomery

http://www.w3.org/2001/XMLSchema#string

P2860

Botulinum Toxin as a Biological Weapon: Medical and Public Health Management

Bacterial toxins: a table of lethal amounts

The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin

Crystal structure of botulinum neurotoxin type A and implications for toxicity

Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E

Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin

Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule.

Passive transfer of protection against Bacillus anthracis infection in a murine model.

Epitope mapping of neutralizing botulinum neurotoxin A antibodies by phage display

Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries.

P304

11346-11350

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.172229899

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

2002-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11210697

http://www.w3.org/2001/XMLSchema#string

P698

12177434

http://www.w3.org/2001/XMLSchema#string

P921

P932

123259

http://www.w3.org/2001/XMLSchema#string